215 related articles for article (PubMed ID: 9647138)
1. Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.
Mössinger H; Dietrich W
Ann Thorac Surg; 1998 Jun; 65(6 Suppl):S45-50; discussion S50-1, S74-6. PubMed ID: 9647138
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
3. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
5. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
6. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R
J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
[TBL] [Abstract][Full Text] [Related]
7. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.
Carrel TP; Schwanda M; Vogt PR; Turina MI
Ann Thorac Surg; 1998 Jul; 66(1):153-8. PubMed ID: 9692456
[TBL] [Abstract][Full Text] [Related]
8. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
9. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
[TBL] [Abstract][Full Text] [Related]
11. Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations.
Dietrich W; Schöpf K; Spannagl M; Jochum M; Braun SL; Meisner H
Ann Thorac Surg; 1998 Jan; 65(1):70-7; discussion 77-8. PubMed ID: 9456098
[TBL] [Abstract][Full Text] [Related]
12. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
13. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery.
Mössinger H; Dietrich W; Braun SL; Jochum M; Meisner H; Richter JA
Ann Thorac Surg; 2003 Feb; 75(2):430-7. PubMed ID: 12607650
[TBL] [Abstract][Full Text] [Related]
14. [Effect of aprotinin on selected parameters of coagulation and drainage blood loss after cardiac operations in patients without coagulation disorders].
Hirnle T; Stachurski A; Goździk W; Pelczar M; Wachnik J; Hirnle G; Milczarska J; Kustrzycki W
Pol Merkur Lekarski; 2006 May; 20(119):543-6. PubMed ID: 16875158
[TBL] [Abstract][Full Text] [Related]
15. Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Kawashima Y
Circulation; 1996 Nov; 94(9 Suppl):II177-81. PubMed ID: 8901742
[TBL] [Abstract][Full Text] [Related]
16. Low doses of aprotinin in aortocoronary bypass surgery--advantages and disadvantages.
Golański R; Golański J; Chizyński K; Iwaszkiewicz A; Zasłonka J; Pietrucha T; Chrul S; Watała C
Med Sci Monit; 2000; 6(4):722-8. PubMed ID: 11208399
[TBL] [Abstract][Full Text] [Related]
17. Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response?
Englberger L; Kipfer B; Berdat PA; Nydegger UE; Carrel TP
Ann Thorac Surg; 2002 Jun; 73(6):1897-904. PubMed ID: 12078788
[TBL] [Abstract][Full Text] [Related]
18. Effects of minimal-dose aprotinin on coronary artery bypass grafting.
Hayashida N; Isomura T; Sato T; Maruyama H; Kosuga K; Aoyagi S
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):261-9. PubMed ID: 9270645
[TBL] [Abstract][Full Text] [Related]
19. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
Dietrich W
J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
[TBL] [Abstract][Full Text] [Related]
20. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
